SCHEMBL4337150

SCHEMBL4337150

COc1ccc(CC(OC(C)C)C(=O)O)cc1NC(=O)OCCc1ccc(Cl)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
NPSR1 Q6W5P4 3/20 0.40
PPARA Q07869 3/20 0.39
GAA P10253 1/20 0.39
ALDH1A1 P00352 4/20 0.39
MMP1 P03956 1/20 0.39
L3MBTL1 Q9Y468 4/20 0.39
PPARG P37231 2/20 0.39
MAPK1 P28482 1/20 0.39
PPARD Q03181 1/20 0.39
CTSD P07339 1/20 0.38
LMNA P02545 2/20 0.38
TSHR P16473 1/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4329430 0.91 PPARA (0.40) SMN1; SMN2MEN1KMT2APPARAGAA
SCHEMBL4328087 0.91 KMT2A (0.44) SMN1; SMN2MEN1KMT2ANPSR1PPARA
SCHEMBL4334231 0.83 SMN1; SMN2 (0.46) SMN1; SMN2MEN1KMT2APPARAALDH1A1
SCHEMBL4332223 0.83 CNR1 (0.45) SMN1; SMN2KMT2ANPSR1PPARAALDH1A1
SCHEMBL4327529 0.83 MAPT (0.42) SMN1; SMN2MEN1KMT2APPARAGAA
SCHEMBL4335087 0.82 KMT2A (0.41) SMN1; SMN2MEN1KMT2ANPSR1PPARA
SCHEMBL4331703 0.82 ADRB2 (0.41) SMN1; SMN2MEN1KMT2ANPSR1PPARA
SCHEMBL4345770 0.81 MAPT (0.47) SMN1; SMN2MEN1KMT2APPARAGAA
SCHEMBL4337947 0.81 PPARA (0.42) SMN1; SMN2MEN1KMT2ANPSR1PPARA
SCHEMBL4328950 0.81 MAPT (0.48) SMN1; SMN2MEN1KMT2ANPSR1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 SMN1; SMN2 3054/4885MEN1 4091/4885KMT2A 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.